As per today's interim results, reveune up by 6%, EBITDA is up by 29%. EBITDA margin is 27%. Look the half-year financial statements, "product and technologies expenses(another name for "R & D") has been down by 44%. That is exactly what I expect: as long as IRI revenue goes up, R & D comes down, its EBITDA margin goes up substantially.
Ann: FY2023 Trading Update, page-18
Add IRI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
93.0¢ |
Change
0.055(6.29%) |
Mkt cap ! $162.3M | |||
| Open | High | Low | Value | Volume |
| 87.0¢ | 94.0¢ | 87.0¢ | $436.8K | 475.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3500 | 92.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.0¢ | 80000 | 2 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IRI (ASX) Chart |